Bank of New York Mellon’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $285K | Buy |
94,117
+75,767
| +413% | +$230K | ﹤0.01% | 3809 |
|
|
2025
Q1 | $78.2K | Buy |
18,350
+2,467
| +16% | +$10.5K | ﹤0.01% | 4008 |
|
|
2024
Q4 | $83.9K | Sell |
15,883
-2,024
| -11% | -$10.7K | ﹤0.01% | 4022 |
|
|
2024
Q3 | $32.8K | Hold |
17,907
| – | – | ﹤0.01% | 4048 |
|
|
2024
Q2 | $37.2K | Hold |
17,907
| – | – | ﹤0.01% | 4060 |
|
|
2024
Q1 | $71.8K | Hold |
17,907
| – | – | ﹤0.01% | 4051 |
|
|
2023
Q4 | $33.6K | Hold |
17,907
| – | – | ﹤0.01% | 4187 |
|
|
2023
Q3 | $29.9K | Hold |
17,907
| – | – | ﹤0.01% | 4209 |
|
|
2023
Q2 | $42.8K | Hold |
17,907
| – | – | ﹤0.01% | 4190 |
|
|
2023
Q1 | $56K | Hold |
17,907
| – | – | ﹤0.01% | 4169 |
|
|
2022
Q4 | $48K | Hold |
17,907
| – | – | ﹤0.01% | 4243 |
|
|
2022
Q3 | $53K | Hold |
17,907
| – | – | ﹤0.01% | 4309 |
|
|
2022
Q2 | $53K | Hold |
17,907
| – | – | ﹤0.01% | 4333 |
|
|
2022
Q1 | $92K | Hold |
17,907
| – | – | ﹤0.01% | 4419 |
|
|
2021
Q4 | $120K | Hold |
17,907
| – | – | ﹤0.01% | 4378 |
|
|
2021
Q3 | $124K | Hold |
17,907
| – | – | ﹤0.01% | 4283 |
|
|
2021
Q2 | $174K | Sell |
17,907
-7,778
| -30% | -$75.6K | ﹤0.01% | 4123 |
|
|
2021
Q1 | $404K | Buy |
25,685
+543
| +2% | +$8.54K | ﹤0.01% | 3800 |
|
|
2020
Q4 | $608K | Buy |
+25,142
| New | +$608K | ﹤0.01% | 3516 |
|
|
2016
Q2 | – | Sell |
-493
| Closed | -$152K | – | 4346 |
|
|
2016
Q1 | $152K | Hold |
493
| – | – | ﹤0.01% | 3862 |
|
|
2015
Q4 | $306K | Hold |
493
| – | – | ﹤0.01% | 3699 |
|
|
2015
Q3 | $274K | Sell |
493
-44
| -8% | -$24.5K | ﹤0.01% | 3764 |
|
|
2015
Q2 | $383K | Buy |
+537
| New | +$383K | ﹤0.01% | 3713 |
|